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Abstract Recent studies have shown that vertebrates, including 
teleostean fishes, amphibians, birds and mammals, contain two 
distinct insulin-like growth factor (IGF) genes. In contrast ag- 
nathans, represented by hagfish, apparently have only one IGF 
that has features characteristic of both IGF-I and IGF-II. Be- 
tween these groups the elasmobranchs occupy a critical position 
in terms of the phylogeny of IGFs. We sought to determine if gene 
duplication and divergence of IGF-I and IGF-II occurred before 
or after divergence of elasmobranchs from other vertebrates by 
cloning IGF-like molecules from Squalus acanthias. Our analysis 
shows that Squalus fiver produces two distinct IGF-like mole- 
cules. One has greater sequence identity to, and conserved fea- 
tures characteristic of, known IGF-I molecules, while the other 
is more IGF-II like. These results suggest hat the prototypical 
IGF molecule duplicated and diverged in an ancestor of the extant 
gnathostomes. 
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1. Introduction 
Insulin-like growth factors (IGFs) are polypeptides that play 
important roles in development and growth [1]. IGFs were 
initially identified as 'sulfation factors' because of their ability 
to stimulate the incorporation of sulfate by cartilage [2], 'non- 
suppressible insulin-like activity' (NSILA) due to insulin-like 
effects on adipose tissue metabolism [3], and 'multiplication 
stimulating activity' (MSA) because they were able to stimulate 
multiplication of chicken embryo fibroblasts [4]. As these fac- 
tors were characterized in greater detail it became vident that 
sulfation factor, NSILA, and MSA were the same or very 
similar molecules. Purification of NSILA from human serum 
and amino acid sequencing revealed two peptides, named insu- 
lin-like growth factor-I and -II, that had significant homology 
to each other as well as proinsulin [5,6]. Like proinsulin, IGF-I 
and IGF-II have a B-, C-, and A-domain. The B- and A- 
domains of proinsulin and IGFs show a high degree of se- 
quence identity while the C-domains have little sequence iden- 
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tity. The C-domain of IGFs is not removed by proteolytic 
processing, as is the case in proinsulin, and in addition, the 
IGFs contain carboxy-terminal sequences that have been 
named the D- and E- domains. The E-domain is removed as 
a post-translational modification to produce mature IGF [7]. 
The development of recombinant DNA technology has stim- 
ulated much work on the evolution of insulin and IGF genes. 
An insulin-like peptide (ILP) cDNA has been cloned from the 
protoochordate Amphioxus californiensis that has characteris- 
tics of both insulin and IGF. ILP contains a B-, C-, and A- 
domain similar to those of proinsulin and IGF. The C-domain 
is flanked by paired basic residues and might thus be removed 
by proteolytic processing as is the case with proinsulin. How- 
ever, the A-domain of ILP is followed by sequences reminiscent 
of the D- and E-domain of IGF. Amphioxus ILP might there- 
fore resemble a prototype insulin/IGF molecule [8]. In contrast, 
the hagfish belongs to the class agnatha (jawless vertebrates) 
and is considered to be one of the most primitive vertebrates. 
Two members of the insulin family have been cloned from the 
Atlantic hagfish [9,10]. One of them is clearly an insulin, while 
the other is an IGF with nearly equal sequence identity to either 
human IGF-I or human IGF-II. This suggests that hagfish IGF 
might represent a prototype IGF molecule. Recently, molecules 
with obvious equence identity to either IGF-I or IGF-II have 
been sequenced from teleosts, amphibians, birds, and mammals 
(see legend to Fig. 2 for specific references). Therefore, an 
important question regarding the evolution of IGF-I and IGF- 
II is when did the gene duplication of the ancestral IGF mole- 
cule occur to give rise to two distinct IGFs? Elasmobranchs are 
a major group of vertebrates that lie between agnathans and 
teleosts on the phylogenetic tree. We sought to address the 
question of IGF divergence by cloning IGF-like molecules 
from an elasmobranch, Squalus acanthias, the spiny dogfish 
shark. 
2. Materials and methods 
Total RNA was prepared from Squalus liver using the guanidine 
thiocyanate procedure [17]. Complementary DNA was synthesized 
from total RNA using random primers and MMLV reverse transcrip- 
tase (Gibco/BRL). PCR amplification was performed for 40 cycles at 
94°C for 1 rain, 50°C for 1 rain 30 s, and 65°C for 1 min 30 s with Taq 
DNA polymerase (Perkin Elmer). Primers used were IGF-9: 5'- 
GCPCAPTACATQTCG/TAG, IGF-10: 5'-GCGCAGTAGFFGTQT- 
CG/TAG, IGF-14: 5"-GAA/GACNCTNTCT/CGGNGG, IGF-15: 5'- 
GAA/GACNCTNTGT/CGGNTC, and IGF-17: 5'-GAA/GACNCT- 
NTGT/CGGNGC, where P = A or G, Q = C or T, and N = A, G, C, 
or T. PCR products were separated by electrophoresis on 8% poly- 
acrylamide gels. Bands of the appropriate size were excised, eluted, and 
cloned into the EcoRV site of pBluescript (Stratagene). The 5' and 3' 
ends of the cDNAs were amplified by RACE [18], gel purified, and 
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blunt-end ligated to pBluescript. DNA sequencing was performed using 
the dideoxynucleotide m thod with Sequenase version 2.0 (United 
States Biochemical). DNA and protein sequence analysis was per- 
formed with GeneWorks version 2.4 from IntelliGenetics. 
3. Results and discussion 
3.1. Cloning of shark IGF-I and IGF-H 
Amino acid sequence alignments of IGF-I and IGF-II se- 
quences from mammals, birds, amphibians, and fish revealed 
regions in the B- and A-domains that were conserved among 
either IGF-I or IGF-II sequences, but not both IGF-I and 
IGF-II. This suggested that degenerate PCR primers made to 
these areas might allow preferential amplification of either 
IGF-I or IGF-II from shark liver cDNA, if both sequences 
existed. Primers IGF-9 and IGF-10 were designed to anneal to 
the LeuGluMetTyrCysAla sequence of the IGF-I A-domain 
and the LeuGluThrTyrCysAla sequence of the IGF-II A-do- 
main, respectively. Primers IGF-17, IGF-14, and IGF-15 were 
designed to anneal to the B-chain sequence GluThrLeu- 
CysGlyAla of IGF-I, GluThrLeuCysGlyGly of IGF-II, and 
GluThrLeuCysGlySer of hagfish IGF, respectively. Various 
combinations of these primers were used for PCR of shark liver 
cDNA. Primer pairs IGF-9/IGF-17 and IGF-10/IGF-15 gave 
PCR products of the expected size of 180 bp. These PCR 
products were cloned and sequenced and found to encode IGF 
sequences. RACE was used to obtain 5' and 3' cDNA se- 
quences. Finally, the entire coding region of each IGF was then 
amplified by PCR with two different primer pairs, cloned and 
sequenced. Each IGF has therefore been amplified by three 
independent PCR reactions in order to verify that the sequence 
is correct. 
3.2. Analysis of shark IGF-I and IGF-H sequences 
We propose that the two distinct IGF sequences that were 
cloned from shark liver cDNA are homologues of the verte- 
brate IGF-I and IGF-II genes based on overall sequence iden- 
tity with mammalian, avian, amphibian, and piscine IGF se- 
quences, as well as conservation of specific residues which ap- 
pear to be unique to either IGF-I or IGF-II. 
Shark IGF-I (Fig. 1A) contains a 24 residue signal peptide. 
Most other IGF-I sequences contain much longer signal pep- 
tides (Fig. 2A). There were no in-frame stop codons found 
upstream of the shark IGF-I signal peptide in the longest 5'- 
RACE product and it is therefore possible that an additional 
initiator methionine residue does exist further upstream. Ma- 
ture shark IGF-I consists of 70 amino acids and has 66% and 
62% sequence identity to human IGF-I and IGF-II, respec- 
Table 1 
Percentage amino acid sequence identity of mature IGF-I vs. IGF-I 
(upper ight) and IGF-II vs. IGF-II (lower left) 
IGF - I  
h . . . .  is%ken f84g t8¢0ut m66rk ha5f51s h h=n 
chicken 84 ~ 89  84 68 56  chicken 
. . . . .  ~ 8 4  63 55 frog 
shark 66 5 9 _  60 ~ 4  shark 
hag f ish 62 5 6 - 5 8  59  ~ a g f i s ~  
human chicken . . .  trout shark hagf ish 
IGF - I I  
A: IGF - I  
tatctacctgcagctcctcctcagaagtctttgaqgttgtgagg~I~CaTGCCTACCCTCCTACCCTCATCTTTTCT 31 
M C L A S Y P S L F Y 
-24 -14 
ACC TGACGCT GT G T GTCC T AAC GCT GAGTGGGGTGGAAGCCAGT CCAGAGAC TCTCT GC GGGGCAGAAT T GG TGG 106 
L T L C V L T L S G V E A $ P E T L C G A E L V D 
-i 1 12 
ACGCTCTCCAGTTTGTGTGTGGGGACCGAGGCTTTTATTTCAACA~ACCTGCGGGCTACAGGTCGAGTGTGAGGC 181 
A L Q F V C G D R G F Y F N K P A G Y R S $ V R R 
37 
GGCCACACAGAGGGATCGTGAATGAGTGC TGCTT TCAGAGCTGTGACCTCAAGCTGCTAGAGATGTACTGCGCAA 256 
P H R G I V N E C C F Q S C D L K L L E M Y C A K 
62 
AGC CGCAAAGAG CAGAC GG T C C T GCAC GCAT CCAAC T T C AC ACT GAGAAAGGAC AGAGGGAA~ACGT C TGGAGAA 331 
P Q R A D G P A ~ I Q L S T E K G Q R E N V W R N 
87 
ACCCCAACCGAACTAACGCCAGCAGTGTCAACCGGAATTACCGAATCtgagatacgagqaactgaagaagggatt 406 
P N R T N A S $ V N R N Y R I * 
102 
gccggcagacctggtccagtgtagccctggtgtgggatcaccataaagcccqccaatcatccacaatcgatgtc 480 
B : IGF- I I  
cccgacacagatcgataacgtttgctgcagctatcagctccgtgttgtttctggactcggctgetccgtggagct -47 
ttcccgtggttagtgcctgggagggtgtacag~aagctgctcgacg~li~GG~CACTCAGCCCTCG~CTCAG 29 
M G R H S A L G L S  
-49 -40 
TGGG~CCGTCAGGTCTCCCCTTGCACGGGGAC~GCCCCTTT~TAGTT~TTCCA~AGCCCTGTGCAGCC 104 
G N R Q V S P C T G T R P F K V V G S R S P V Q p  
-15 
ACTGTGCATCTT~TTGCTCTCACTGTTTGCATCGGGACATCTGAGGCGCGACTGGA~AGAC~TATGTGGATC 179 
L C I L L A L T V C I G T S E A R L E E T L C G $  
-i 1 ii 
GG~CTCGTGGACACACT~AGTTCATCTGTGCGGAAAGGGGCTTTTATTTTGTCAGCAAAGTGGTGGGTCGTCG 254 
E L V D T L Q F I C A E R G F Y F V S K V V G R R  
36 
GAGCC~CAG~CCGAGGCATCGTGGAGG~TGCTGCTTCCGTAGCTGTGACCTTCTGATACT~AGACCTACTG 329 
S R Q N R G I V E E C C F R S C D L L I L E T Y C  
61 
CGCAGTCCCGCCAGAG~AGCCAGATCCACACCTTCCCCGGCAC~CAGAGGACACTGATGCACCGGATCGTGGG 404 
A V P P E A A R S T P S P A Q Q R T L M H R I V G  
86 
G~GCGGTCGCTCGGCATTG~CAGGA~CTCACCCGGCCT~A~ACACCTGCA~TACCTG~C~C~ 479 
K R S L G I E Q E R L T R P G G H L Q Q Y L N N A  
iii 
~GTCCTGCTTCCTCGCCCb-~GCTGAGATCCTTGACTGGCCGGGAGAGGGCG~GCGTCGCCGCCCATCGGTGA 554 
S P A S S P K A E I L D W P G E G E A S P P I G D  
136 
CCTCACCTGGCGCGCGCGGTACCCGCCCCGGC. 'GGGTGTGGCTGA~GCGGCGCT~CCTCTCCTTCGACGTC 629 
L T W R A R Y P P R H W V W L S A A L P S P S T $  
161 
Ctaaaccgttctqaatgcacgggqagtgtcgaactgtttaagttgatetttgacctttgaggaggacgcggccac 704 
gtgaccagccgatgaggccgcgctggcaac 734 
Fig. 1. Nucleotide and deduced amino acid sequence of shark IQF-I 
(A) and IGF-II (B). The cDNA sequence is shown on top and num- 
bered at right. 5' and 3' untranslated sequences are indicated by lower 
case letters and the coding region is shown in upper case letters. The 
initiator methionine codon is underlined and the stop codon is indicated 
by an asterisk. The deduced amino acid sequence is represented by the 
single letter code and numbered below. 
tively (Tables 1 and 2). Conserved residues common to all 
IGF-I sequences, including shark, but not IGF-II sequences are 
Pro 2 and Ala s of the B- domain, Gly3°Tyr 31 of the C-domain, 
and Met 59 of the A-domain (Fig. 2A). We also note that all 
IGF-I D-domains are 8 or 9 amino acids long and all IGF-II 
D-domains are 6 amino acids in length. 
The shark IGF-I E-domain contains 32 amino acids. IGF-I 
E-domains from other species are 35 amino acids long but 
longer forms can be generated by alternative splicing ofmRNA 
[19,20]. PCR amplification of the E-domain region of shark 
IGF-I yielded a single band (data not shown), suggesting that 
alternative splicing does not occur in shark liver. All IGF-I 
E-domains begin after arginines, which have been shown to be 
necessary for proteolytic removal of the E-domain during pro- 
hormone processing. The lysine residue at position 68 is also 
required for processing [21]. It is interesting that shark IGF-I 
contains a glycine in position 68. We have previously shown 
that substitution of Lys 68 in human IGF-I with glycine com- 
pletely inhibits processing at Arg 71 [21]. This suggests hat shark 
proIGF-I might not be processed to mature IGF-I, or acom- 
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A:  IGF - I  
signal peptide 
-48 -I 
human MGKISSLPTQLFKCCFCDFLKVKMHTMSSSHLFYLALCLLTFTSSAT-A  
chicken MEKINSLSTQLVKCCFCDFLKVKMHTVSY IHFFYLGLCLLTLTSSAA-A  
frog METNNNLSTQLFKCYFCDILKLKMHKMSCIHLLYLVLCFLTLTHSAA-A  
t rout  MS . . . . .  SGHFFQWHLCDVFKSAMCCVSCTHTLSLLLC IFLTLTSAATGA 
shark M . . . . . . . . . . . . . . .  C - -L  . . . . . .  ASYPHLFYLTLCVLTLSGVE- -A  
hagfish Y . . . . . .  IRRVRQGSIYSLL -VESQ-QWCKLTLTLLL -LLALLTRC- -T  
B -domain  
1 29 
Gp~E TLCGAELVD ALQFVCGD RGFYF  - - -NKPT  
GEE TLCGAELVD ALQFVCGD RGFYF  - - -SKPT 
GPETLCG~LVD TLQFVCGD~-  - - S Kp  T 
GPE TLCG~LVD T LQFVCGER~F3~F - - - S KP  T 
S~ETLCC~LVDALQFVCGDRGFYF  - - -NKPA 
L S ETLCGSELVDTLQFVCDDRGFFFVP QHVPP 
C-domain A-domain  D-domain  
30 41 42 62 63 70 
human ~YGS S SRRApQT G IVDECCFRSCD LRRLE~CA PLKPAKSA 
chicken GYGSSSRRLHHK G IVDECCFQSCDLRRLE~ P IKPPKSA 
frog GYGSNNRRSHHR GIVDECCFQSCDF~ PAKPAKSA 
trout GYGP S SRRS HNR G IVDECCFQSCEL~ pVKSGKAA 
shark F~RS SVRRP H-R  G IVNECCFQSCD LKLLEMYCA KPQRADGPA 
hagfish RRGAHRRSRABK G IVEECCFKGCS LRLLE~YCA - -RPSKAE 
E-domain 
71 105 
RSVRA~R~MPKTQKEVHLK~ASRGSAGNKNY~M 
RSVRA~R~DMPKAQKEVHLK~TSRGNTGNRNy~M 
RSVRAQR~2DMPKAQKEVHPK~TSRGNTGSRGF~M 
RSVRAQR~L~DMPRTPKEVHQK~SSRGNTGGRNY~M 
R- I - -~L~EKGQRENVWRNP~RTNASSVNRNY~I  
RDV- -ARPEQRPHRASQ-HSRRGSQSRGRGRSR- -  
B: IGF - I I  
signal peptide 
~4 -i 
human M . . . . . . . . . . . . . . . . . . .  GIPMGKSMLVLLTFLAFASCCIA . . . . . .  
chicken 
trout METQKRBEYHSVCHTCRRTENTRMKVF/~MSSSNRVLVIALALTLYIV--  
shark MGRHSALGLSGNRQVSPCTGTRPFKWGSRSPVQPLCILLALTVCIGTS 
hagfish YIRRV~QG . . . . . . . . . . .  S IYSLLVESQQWCKLTLTLLLLLALLTRCT 
B-domain 
1 32 
AYRP S ETLCGGELVDTLQFVCGDRGF~F -S RP A 
- YG T AETLCGGELVDTLQFVCGDRGF~/F - S RP V 
ErAS AETLCGGELVDALQFVCEDRGFX~F - S RP T 
EAR LEETLCGSE LVD T I~F I CAERG~"/FVS KW 
- - - LSETLCGSELVDTLQFVCDDRGFFFVPQHV 
C-domain 
33 4o 
human -SRV--SRR-- -SR 
chicken -GRN--NRR---  IN 
trout -SRS-NSRRSQ-NR 
shark -GRR--SRQ-- -NR 
hagfish P PRRGAHRRSRARK 
A-domain D-domain 
41 61 62 67 
G IA~CCFRSCDLALLE  TYCA TPAKSE 
GIV~ECCFRSCD LALLXTYCA TPAKSE 
GIV~ECCFRSCDLNL EQyCA KPAKSE 
G~CFRSCDLL  ILETYCA VPPEAA 
G IV~EC(~KGCS LRLLEMYCA RPSKAE 
E-domaln 
68 
RDVSTPP . . . . . . .  TVLPDNFPRYPVG-KFFQYDTW-KQST~I~ 
RDVSATSLQI IPMVPT IKQDVPRKHVTVKYSKYEAWQRKA~ 
RSTPSPAQQ .. . .  RTLMHRIVGKRSLGIEQERLTRPGGHLQ~Y~ 
RDVARPRQR . . . . . . . . . . . .  PH . . . . . . . . . . . . . . .  RAS~S 
human 
chicken 
trout 
shark 
hagfish 
157 
RRGL~LLR/~RR GHVLAKE LEAFREAKRHRP L i ALP TQDPAHGGAPP EFL~SNRK 
RR~ILRARKFRRQAVKIK~EQAMFHRPL ITLPSKLP-PVLPPTDNYVSHN 
NNASPASSPKAEILDWPGEGF~-SPPIGDLTWRARYPpRHWVWLSAALPSPSTS 
RRGSQSRGRGR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  SR 
Fig. 2. Amino acid alignment of IGF-I (A) and IGF-II (B) sequences. Amino acids are represented by the single letter code and numbering corresponds 
to human IGF-I residues. Residues conserved in all species are indicated by bold-faced type and residues that are unique to either IGF-I or IGF-II 
are underlined. References for sequences are as follows: human IGF-I and -II [11,12], chicken IGF-I and -II [13,14], frog IGF-I [15], trout IGF-I 
and -II [16], and hagfish IGF [10]. 
pensatory mutation may have occurred in the shark proIGF-I 
processing enzyme such that it still cleaves the substrate. It is 
also possible that shark proIGF-I is processed at an alternative 
LysXaaXaaArg site, such as LysProGlnArg 65 or LysGlyGln- 
Arg 81. Residues that are conserved in all IGF-I sequences but 
not found in the IGF-II E-domains are Gln 76, HisTSyhr 79, the 
Asn92XaaSer/Thr N-glycosylation site, and Arg 1°4. Despite low 
sequence identity with E-domains of IGF-I from other species, 
the basic nature (calculated pI = 11.81) of the shark IGF-I 
E-domain is conserved. 
Shark IGF-II has a signal peptide that is 49 amino acids long 
and preceded by an in-frame stop codon 36 nucleotides up- 
stream of the initiator methionine codon (Fig. 1B). Mature 
shark IGF-II is 68 amino acids long and has 66% and 55% 
sequence identity with human IGF-II and IGF-1, respectively 
(Tables 1 and 2). The only residue that is conserved and unique 
to all IGF-II sequences, compared to IGF-I, is Glu 44 of the 
A-domain (Fig. 2B). However, shark IGF-II contains several 
other features that are hallmarks of 1GF-II sequences. The 
GluThrLeuCysGly sequence found in all IGF B-domains is 
preceded by two amino acids in IGF-I sequences but by 4 or 
5 residues in IGF-II sequences. Comparison of IGF-I and IGF- 
II A-domain sequences reveals a Leu/PheArgArgLeu 57 motif in 
IGF-I. The homologous region in IGF-II contains hydropho- 
Table 2 
Percentage amino acid sequence identity of mature IGF-I vs. mature IGF-II 
IGF-I 
human chicken frog trout shark hagfish 
human 63 62 64 60 62 62 
IGF-II chicken 63 61 65 57 58 56 
trout 67 66 67 62 62 58 
shark 55 55 53 59 55 59 
hagfish 55 56 55 55 54 - 
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bic residues in place of the basic residues found in IGF-I. Shark 
IGF-II contains two hydrophobic residues in this motif. Shark 
IGF-II also contains a 6 amino acid D-domain whereas IGF-I 
D-domains are 8 or 9 amino acids long (Fig. 2). 
IGF-II E-domains tend to be longer than IGF-I E-domains 
and have not been found to be alternatively spliced. The shark 
IGF-II E-domain follows this trend. It is 84 amino acids long 
and no evidence for alternative splicing was obtained using 
RT-PCR analysis (data not shown). As noted previously [20], 
both IGF-I and IGF-II E-domains from all species are ex- 
tremely basic. The predicted isoelectric point of the shark IGF- 
II E-domain is 11.47. The LysXaaXaaArg motif identified as 
required for processing of proIGF-I [21] has been conserved in 
the D/E-domain junction of all IGF-II sequences except shark 
IGF-II, where Glu has been substituted for Lys. Given the 
importance of basic residues for prohormone processing, it is 
surprising to find that an acidic residue has been substituted for 
Lys. However, it is possible that the shark proIGF-II process- 
ing enzyme may still cleave this precursor, or that shark 
proIGF-II is secreted unprocessed but still retains appropriate 
biological activity. Residues that are conserved in all IGF-II 
sequences but not found in the IGF-I E-domains are Gln 1°°, 
Leu 1°2, Prol°VAlal°8, and Ala 124. 
Our results how that shark liver contains two distinct IGFs, 
one homologous to IGF-I and the other homologous to IGF- 
II. This indicates that the ancestral IGF gene duplicated before 
chondrichthyes diverged from the tetrapod lineage, more than 
440 million years ago. Furthermore, sequence comparisons 
demonstrate that IGF-I and IGF-II have evolved slowly during 
vertebrate evolution. Thus, gnathostome IGF-I sequences are 
more similar to each other than to IGF-II, and gnathostome 
IGF-II sequences are more similar to each other than to IGF-I 
(Tables 1 and 2). On the other hand, hagfish IGF has character- 
istics of gnathostome IGF-I and IGF-II. Like IGF-I sequences, 
hagfish IGF has a longer C-domain, a methionine residue at 
position 59 of the A-domain, and a short E-domain. However, 
hagfish IGF lacks the GlyTyr sequence found at the beginning 
of all IGF-I C-domains. It also contains the invariant glutamate 
found at position 44 of the A-domain of all IGF-II sequences, 
has the 6 amino acid D-domain characteristic of IGF-II mole- 
cules, and shows slightly higher sequence identity to human, 
trout, and shark IGF-II than IGF-I. As noted above, IGF-I 
sequences contain a Leu/PheArgArgLeu 57 motif in the A-chain 
while IGF-II sequences do not have basic residues in this area 
but tend to be hydrophobic. The homologous region in the 
hagfish A-domain is intermediate: LeuArgLeuLeu. This analy- 
sis indicates that hagfish IGF contains features characteristic 
of and distinct to both IGF-I and IGF-II, while elasmobranchs, 
teleosts, amphibian, birds and mammals contain IGFs which 
are clearly either IGF-I or IGF-II molecules, thus supporting 
the hypothesis that hagfish IGF may predate the ancestral 
molecule that duplicated and diverged to generate gnathostome 
IGF-I and IGF-II [22]. 
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